TUMOUR IMMUNOTHERAPY PROGRAM - TIP
THE PRINCESS MARGARET LEADS THE WAY
Princess Margaret Cancer Centre is home to Canada’s first and most comprehensive immunotherapy program. Our cutting-edge research expertise spans basic immunology discoveries to clinical trials. We focus on improving our knowledge of the immune system to better detect, diagnose and target cancers.
KEY FEATURES OF TIP
Next generation of immune therapies:
We’re conducting studies to understand how a T-cell response can be regulated and augmented to improve its ability to kill cancer cells.
New clinical trials of combination therapies:
We’re combining different therapeutic strategies to improve the immune response and provoke a stronger attack on a patient’s cancer.
TCR gene transfer trial:
We have opened the first clinical trial in Canada that uses genetically engineered T-cells to kill off cancer cells when given to patients.
We’re developing a comprehensive database of clinical data from patients who have undergone immunotherapy that will inform future treatments.